Does ARSENIC TRIOXIDE Cause Hyperleukocytosis? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Hyperleukocytosis have been filed in association with ARSENIC TRIOXIDE (Vermasode). This represents 4.2% of all adverse event reports for ARSENIC TRIOXIDE.
49
Reports of Hyperleukocytosis with ARSENIC TRIOXIDE
4.2%
of all ARSENIC TRIOXIDE reports
1
Deaths
26
Hospitalizations
How Dangerous Is Hyperleukocytosis From ARSENIC TRIOXIDE?
Of the 49 reports, 1 (2.0%) resulted in death, 26 (53.1%) required hospitalization, and 2 (4.1%) were considered life-threatening.
Is Hyperleukocytosis Listed in the Official Label?
Yes, Hyperleukocytosis is listed as a known adverse reaction in the official FDA drug label for ARSENIC TRIOXIDE.
What Other Side Effects Does ARSENIC TRIOXIDE Cause?
Differentiation syndrome (180)
Electrocardiogram qt prolonged (148)
Off label use (128)
Acute promyelocytic leukaemia differentiation syndrome (51)
Drug ineffective (45)
Acute kidney injury (42)
Leukaemia recurrent (41)
Hypokalaemia (40)
Idiopathic intracranial hypertension (38)
Pericarditis (34)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
DOXORUBICIN (36)
Which ARSENIC TRIOXIDE Alternatives Have Lower Hyperleukocytosis Risk?
ARSENIC TRIOXIDE vs ARTEMETHER\LUMEFANTRINE
ARSENIC TRIOXIDE vs ARTESUNATE
ARSENIC TRIOXIDE vs ARTICAINE\EPINEPHRINE
ARSENIC TRIOXIDE vs ASCIMINIB
ARSENIC TRIOXIDE vs ASCORBIC ACID